← Open Payments lookup

KRISTINE MIMS: Open Payments

NPI 1164092532 · CICERO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,563 in 133 payments from 15 companies in 2025. Trend: 2023 $2,702 · 2024 $1,933 · 2025 $2,563

Food & beverage: $2,563
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)28$507
Teva Pharmaceuticals USA, Inc.23$430
E.R. Squibb & Sons, L.L.C.16$344
Vanda Pharmaceuticals Inc.9$277
Alkermes, Inc.15$230
Neurocrine BioSciences, Inc.11$204
Otsuka America Pharmaceutical, Inc.11$194
ABBVIE INC.10$190
Takeda Pharmaceuticals U.S.A., Inc.3$42
Lundbeck LLC2$41

Products named: CAPLYTA, AUSTEDO XR, COBENFY, ARISTADA, INGREZZA, VRAYLAR, HETLIOZ, REXULTI.

Industry payments across NY — which companies pay providers there.